
Azulfidine
500mg
Sulfasalazine 500mg tablets, used in the management of rheumatoid arthritis, ulcerative colitis and Crohn's disease. A sulfonamide DMARD.
Crohn’s disease is relapsing immune-mediated inflammation that can affect any digestive-tract segment and cause narrowing, fistulas or abscesses.

500mg
Sulfasalazine 500mg tablets, used in the management of rheumatoid arthritis, ulcerative colitis and Crohn's disease. A sulfonamide DMARD.

2.5mg
Methotrexate 2.5mg tablets, used in the management of rheumatoid arthritis, psoriasis and Crohn's disease. A folic acid antagonist blocking dihydrofolate reductase.
The listings below are not interchangeable Crohn’s therapies; disease location, behaviour, severity and infection risk guide selection.
Blood and stool inflammation markers, ileocolonoscopy and small-bowel imaging define extent and activity. Perianal examination matters when pain or drainage is present. Anaemia, nutrition, bone health and extraintestinal joint, skin or eye disease are assessed alongside bowel symptoms.
Immunomodulators, biologics and targeted oral medicines have different mechanisms, onset and monitoring needs. Screening for tuberculosis, hepatitis and vaccination status precedes significant immune suppression. Surgery treats obstruction, abscess or damaged bowel but does not eliminate the underlying tendency to recur.
Seek urgent care for severe or increasing abdominal pain, repeated vomiting, a swollen abdomen, inability to pass stool or gas, heavy bleeding, high fever or a painful perianal swelling.